Nanofabricated particles for engineered drug therapies: A preliminary biodistribution study of PRINT™ nanoparticles
- 1 August 2007
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 121 (1-2) , 10-18
- https://doi.org/10.1016/j.jconrel.2007.05.027
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticlesInternational Journal of Pharmaceutics, 2006
- Polymer conjugates: nanosized medicines for treating cancerTrends in Biotechnology, 2006
- Designing dendrimers for biological applicationsNature Biotechnology, 2005
- Direct Fabrication and Harvesting of Monodisperse, Shape-Specific NanobiomaterialsJournal of the American Chemical Society, 2005
- The dawning era of polymer therapeuticsNature Reviews Drug Discovery, 2003
- Theoretical considerations of RES-avoiding liposomes: Molecular mechanics and chemistry of liposome interactionsAdvanced Drug Delivery Reviews, 1998
- One billion transistors, one uniprocessor, one chipComputer, 1997
- Engineering liposomes for drug delivery: progress and problemsTrends in Biotechnology, 1995
- Block copolymer micelles as long-circulating drug vehiclesAdvanced Drug Delivery Reviews, 1995
- 5-(3-carboxymethoxyphenyl)-2-(4,5-dimethylthiazolyl)-3-(4-sulfophenyl)tetrazolium, inner salt (MTS) and related analogs of 3-(4,5-dimethylthiazolyl)-2,5-diphenyltetrazolium bromide (MTT) reducing to purple water-soluble formazans As cell-viability indicatorsBioorganic & Medicinal Chemistry Letters, 1991